Skip to main content
CYCLOPHARM LIMITED logo

CYCLOPHARM LIMITED — Investor Relations & Filings

Ticker · CYC ISIN · AU000000CYC5 LEI · 9845008C9R4608FB7007 ASX Manufacturing
Open in API
Filings indexed 777 across all filing types
Latest filing 2016-06-27 Director's Dealing
Country AU Australia
Listing ASX CYC

About CYCLOPHARM LIMITED

https://www.cyclopharm.com.au

Cyclopharm Limited focuses on the development and commercialization of specialized medical imaging technologies. Its primary product, Technegas, is an ultra-fine dispersion of carbon nano-particles labeled with Technetium-99m, utilized for functional lung ventilation imaging. This technology is used to diagnose Pulmonary Embolism by providing high-resolution images via the inhalation of a radioactive aerosol. Technegas is generated on-site using proprietary equipment and is compatible with SPECT and SPECT/CT imaging. The system is engineered to provide diagnostic clarity even in patients with underlying airway diseases. Beyond its primary diagnostic use, the company investigates applications for its technology in managing chronic obstructive pulmonary disease (COPD), asthma, and lung cancer.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice 2 pages 239.7KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including the number of shares disposed and acquired, nature of interest, and related contract information. This type of document is a regulatory filing specifically reporting personal share transactions by company directors and executives, commonly known as insider trades. It is not an annual report, earnings release, or any other financial report but a director's dealing notice. The document length is 3388 characters, consistent with a detailed director's dealing notice. Therefore, the correct classification is 'DIRS' (Director's Dealing).
2016-06-27 English
Change of Director's Interest Notice 2 pages 254.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including number of shares held before and after the change, nature of the change, and related considerations. There is no financial performance data, earnings information, or management discussion. The document is a formal notification of a director's personal share transactions, which fits the definition of Director's Dealing filings. The document length is 3688 characters, which is typical for such notices. Therefore, the correct classification is Director's Dealing (DIRS).
2016-06-27 English
CYC Signs Agreement with the Canadian Association of Nuc Med 2 pages 561.9KB
Regulatory Filings Classification · 95% confidence The document is a press release announcing a strategic partnership agreement between Cyclopharm Limited and the Canadian Association of Nuclear Medicine. It discusses the terms and objectives of the collaboration, including financial support and joint advocacy efforts. There is no financial data, regulatory filing, or report attached or referenced as being published. The content is an announcement of a corporate collaboration rather than a financial report, regulatory filing, or management update. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is best classified as a general regulatory announcement about a corporate partnership, which falls under Regulatory Filings (RNS) as a fallback category for miscellaneous announcements that do not fit other specific categories.
2016-06-26 English
Trading Update & Record Technegas Order Received from China 3 pages 332.9KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Trading Update for First Half 2016 and Record Technegas Order Received from China' and provides detailed financial and operational updates for the half year ended 30 June 2016. It includes forecast and actual sales revenue, gross margin, profit before tax, and discusses strategic priorities and significant orders. The document is approximately 8,092 characters long, which is substantial and contains substantive financial data and analysis for the half year period. It is not a full annual report but a comprehensive interim update with financial figures and business commentary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2016
2016-06-20 English
Chairman's Address to Shareholders 4 pages 372.8KB
AGM Information Classification · 95% confidence The document is a transcript of the Chairman's Address at the Annual General Meeting (AGM) of Cyclopharm Limited held on 11 May 2016. It includes the declaration of quorum, introduction of directors and management, references to the AGM notice, financial statements, auditor's report, and other meeting materials. The content focuses on the company's performance in 2015, strategic updates, and shareholder information typically presented at an AGM. The document is about 8571 characters long, which is consistent with a detailed AGM presentation or address. There is no indication that this is the full Annual Report or a financial statement filing, but rather the speech and presentation materials shared during the AGM. Therefore, the document fits the category of AGM Information (AGM-R).
2016-05-10 English
Managing Director's AGM Presentation 29 pages 1.1MB
AGM Information Classification · 95% confidence The document is titled '2016 Annual General Meeting' and contains detailed presentations including the Chairman's Address, Managing Director's Review, strategy, financial highlights for 2015, product overviews, and formal business including resolutions and voting results. It includes extensive financial data and strategic outlook but is clearly structured as materials presented at the Annual General Meeting. The presence of voting results and formal business resolutions further supports this classification. The document length is substantial (15,000 characters) and contains detailed content typical of AGM presentations rather than a brief announcement or a full annual report. Therefore, the document fits the category of AGM Information (AGM-R).
2016-05-10 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.